Aarti Drugs Limited

NSEI:AARTIDRUGS Rapport sur les actions

Capitalisation boursière : ₹47.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Aarti Drugs Bilan de santé

Santé financière contrôle des critères 5/6

Aarti Drugs possède un total de capitaux propres de ₹12.8B et une dette totale de ₹5.6B, ce qui porte son ratio d'endettement à 44%. Son actif total et son passif total sont ₹24.3B et de ₹11.5B. L'EBIT de Aarti Drugs est ₹2.5B ce qui fait que son ratio de couverture des intérêts 7.4. Elle dispose de liquidités et de placements à court terme de ₹207.7M.

Informations clés

44.0%

Ratio d'endettement

₹5.64b

Dette

Ratio de couverture des intérêts7.4x
Argent liquide₹207.70m
Fonds propres₹12.82b
Total du passif₹11.50b
Total des actifs₹24.32b

Mises à jour récentes de la santé financière

Recent updates

We Discuss Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Sep 20
We Discuss Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet

Sep 05
Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet

Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?

May 04
Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?

Aarti Drugs Limited Recorded A 9.0% Miss On Revenue: Analysts Are Revisiting Their Models

Feb 01
Aarti Drugs Limited Recorded A 9.0% Miss On Revenue: Analysts Are Revisiting Their Models

Aarti Drugs (NSE:AARTIDRUGS) Is Due To Pay A Dividend Of ₹1.00

Jan 30
Aarti Drugs (NSE:AARTIDRUGS) Is Due To Pay A Dividend Of ₹1.00

Aarti Drugs' (NSE:AARTIDRUGS) Anemic Earnings Might Be Worse Than You Think

May 17
Aarti Drugs' (NSE:AARTIDRUGS) Anemic Earnings Might Be Worse Than You Think

These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well

We Take A Look At Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Has Earned Their Pay Packet

Aug 28
We Take A Look At Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Has Earned Their Pay Packet

Here's Why We Think Aarti Drugs (NSE:AARTIDRUGS) Is Well Worth Watching

Aug 19
Here's Why We Think Aarti Drugs (NSE:AARTIDRUGS) Is Well Worth Watching

Is Aarti Drugs Limited (NSE:AARTIDRUGS) Expensive For A Reason? A Look At Its Intrinsic Value

May 17
Is Aarti Drugs Limited (NSE:AARTIDRUGS) Expensive For A Reason? A Look At Its Intrinsic Value

Here's Why I Think Aarti Drugs (NSE:AARTIDRUGS) Is An Interesting Stock

Apr 04
Here's Why I Think Aarti Drugs (NSE:AARTIDRUGS) Is An Interesting Stock

Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?

Mar 17
Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?

Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 02
Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

What Percentage Of Aarti Drugs Limited (NSE:AARTIDRUGS) Shares Do Insiders Own?

Feb 17
What Percentage Of Aarti Drugs Limited (NSE:AARTIDRUGS) Shares Do Insiders Own?

Why Aarti Drugs Limited (NSE:AARTIDRUGS) Should Be In Your Dividend Portfolio

Feb 04
Why Aarti Drugs Limited (NSE:AARTIDRUGS) Should Be In Your Dividend Portfolio

What Can We Learn About Aarti Drugs' (NSE:AARTIDRUGS) CEO Compensation?

Jan 22
What Can We Learn About Aarti Drugs' (NSE:AARTIDRUGS) CEO Compensation?

Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 432% Share Price Increase Shows How Capitalism Can Build Wealth

Jan 07
Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 432% Share Price Increase Shows How Capitalism Can Build Wealth

If You Like EPS Growth Then Check Out Aarti Drugs (NSE:AARTIDRUGS) Before It's Too Late

Dec 23
If You Like EPS Growth Then Check Out Aarti Drugs (NSE:AARTIDRUGS) Before It's Too Late

Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly

Dec 08
Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly

Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Nov 23
Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

How Much Of Aarti Drugs Limited (NSE:AARTIDRUGS) Do Insiders Own?

Nov 08
How Much Of Aarti Drugs Limited (NSE:AARTIDRUGS) Do Insiders Own?

Here's What We Learned About The CEO Pay At Aarti Drugs Limited (NSE:AARTIDRUGS)

Oct 11
Here's What We Learned About The CEO Pay At Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 514% Share Price Increase Shows How Capitalism Can Build Wealth

Sep 23
Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 514% Share Price Increase Shows How Capitalism Can Build Wealth

Aarti Drugs Limited's (NSE:AARTIDRUGS) Business Is Trailing The Market But Its Shares Aren't

Sep 10
Aarti Drugs Limited's (NSE:AARTIDRUGS) Business Is Trailing The Market But Its Shares Aren't

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de AARTIDRUGS ( ₹13.2B ) dépassent ses passifs à court terme ( ₹8.0B ).

Passif à long terme: Les actifs à court terme de AARTIDRUGS ( ₹13.2B ) dépassent ses passifs à long terme ( ₹3.5B ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de AARTIDRUGS ( 42.4% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de AARTIDRUGS a été réduit de 93.3% à 44% au cours des 5 dernières années.

Couverture de la dette: La dette de AARTIDRUGS est bien couverte par le flux de trésorerie opérationnel ( 63.6% ).

Couverture des intérêts: Les paiements d'intérêts de AARTIDRUGS sur sa dette sont bien couverts par l'EBIT ( 7.4 x couverture).


Bilan


Découvrir des entreprises saines